Details for New Drug Application (NDA): 206781
✉ Email this page to a colleague
NDA 206781 describes DEXAMETHASONE SODIUM PHOSPHATE, which is a drug marketed by Amneal, Bel Mar, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Geneyork Pharms, Gland, Hikma, Intl Medication, Luitpold, Lyphomed, Micro Labs, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz, and is included in forty NDAs. It is available from twenty-two suppliers. Additional details are available on the DEXAMETHASONE SODIUM PHOSPHATE profile page.
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 206781
| Tradename: | DEXAMETHASONE SODIUM PHOSPHATE |
| Applicant: | Eugia Pharma |
| Ingredient: | dexamethasone sodium phosphate |
| Patents: | 0 |
Pharmacology for NDA: 206781
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 206781
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 206781 | ANDA | A-S Medication Solutions | 50090-3300 | 50090-3300-0 | 25 VIAL, MULTI-DOSE in 1 CARTON (50090-3300-0) / 30 mL in 1 VIAL, MULTI-DOSE |
| DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 206781 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1432 | 51662-1432-1 | 30 mL in 1 VIAL, MULTI-DOSE (51662-1432-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4MG PHOSPHATE/ML | ||||
| Approval Date: | Dec 1, 2015 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
